https://www.selleckchem.com/pr....oducts/rocilinostat-
re needed to rigorously evaluate the safety and efficacy of antimigraine therapies in this population.Functional neurologic disorder (FND), although neglected for much of the 20th century, is among the most common conditions encountered by neurologists across clinical settings. High prevalence rates and limited provider expertise in FND have created a considerable need to develop educational initiatives and practical suggestions to guide neurologists in training working with this population. To help avoid diagnostic errors